UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 481.

A

Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; (2011) The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. SCIENCE , 334 (6052) pp. 89-94. 10.1126/science.1209202.

Agostinelli, C; Hartmann, S; Klapper, W; Korkolopoulou, P; Righi, S; Marafioti, T; Piccaluga, PP; (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. HISTOPATHOLOGY , 59 (4) pp. 679-691. 10.1111/j.1365-2559.2011.03981.x.

Aguilera, R; Saffie, C; Tittarelli, A; Gonzalez, FE; Ramirez, M; Reyes, D; Pereda, C; (2011) Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. CLIN CANCER RES , 17 (8) 2474 - 2483. 10.1158/1078-0432.CCR-10-2384.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Akers, NK; Curry, JD; Conde, L; Bracci, PM; Smith, MT; Skibola, CF; (2011) Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma , 52 (1) pp. 53-58. 10.3109/10428194.2010.532888.

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; Murphy, M; (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: (pp. pp. 62-63).

Aleman, MM; Gardiner, C; Harrison, P; Wolberg, AS; (2011) Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost , 9 (11) pp. 2251-2261. 10.1111/j.1538-7836.2011.04488.x.

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; Fagone, P; (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. NEUROBIOL DIS , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Gold open access

Amary, MF; Bacsi, K; Maggiani, F; Damato, S; Halai, D; Berisha, F; Pollock, R; (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J PATHOL , 224 (3) 334 - 343. 10.1002/path.2913.

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) pp. 1262-1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, Y; Colman, SM; Kempski, H; (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356-+. 10.1038/nature09650.

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; Atra, A; (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arce, F; Breckpot, K; Collins, M; Escors, D; (2011) Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev , 7 (4) pp. 248-260. 10.2174/157339411797642605. Green open access
file

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. ARTHRITIS RHEUM-US , 63 (1) 84 - 95. 10.1002/art.30099.

Arkenau, HK; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? Ann Oncol , 22 (1) pp. 239-240. 10.1093/annonc/mdq676.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) pp. 392-398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) pp. 832-840. 10.1002/cncr.25636.

Arrieta Bolanos, ER; Maldonado-Torres, H; Dimitriu, O; Hoddinott, MA; Fowles, F; Shah, A; Órlich-Pérez, P; (2011) HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley Population and its relationship to worldwide populations. Human Immunology , 72 (1) pp. 80-86. 10.1016/j.humimm.2010.10.005.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) pp. 295-305. 10.1007/s00439-011-1002-0.

Averbuch, D; Chapgier, A; Boisson-Dupuis, S; Casanova, JL; Engelhard, D; (2011) The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1. Pediatr Infect Dis J , 30 (4) pp. 352-355. 10.1097/INF.0b013e3181fdff4a.

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL

B

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; Sjoholm, R; (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; Davis, R; (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; Sjoholm, R; (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Banks, MR; Haidry, R; Butt, MA; Whitley, L; Stein, J; Langmead, L; Bloom, SL; (2011) High resolution colonoscopy in a bowel cancer screening program improves polyp detection. WORLD JOURNAL OF GASTROENTEROLOGY , 17 (38) pp. 4308-4313. 10.3748/wjg.v17.i38.4308. Gold open access

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, HT; Graeven, U; (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) pp. 24-29. 10.3816/CCC.2011.n.003.

Barton, S; Swanton, C; (2011) Recent developments in treatment stratification for metastatic breast cancer. Drugs , 71 (16) pp. 2099-2113. 10.2165/11594480-000000000-00000.

Bateman, A; Agrawal, S; Birney, E; Bruford, EA; Bujnicki, JM; Cochrane, G; Cole, JR; (2011) RNAcentral: A vision for an international database of RNA sequences. RNA , 17 (11) pp. 1941-1946. 10.1261/rna.2750811.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Accessing and selecting genetic markers from available resources. Methods Mol Biol , 760 pp. 1-17. 10.1007/978-1-61779-176-5_1.

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) pp. 16217-16222. 10.1073/pnas.1107692108.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; Flutter, B; (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. BLOOD , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Bennett, K; James, C; Mutair, A; Al-Shaikh, H; Sinani, A; Hussain, K; (2011) Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene. PEDIATRIC DIABETES , 12 (3) pp. 192-196. 10.1111/j.1399-5448.2010.00683.x.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; Tan, IB; (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) pp. 3447-3452. 10.1158/0008-5472.CAN-10-3667.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Blanc, V; Nariculam, J; Munson, P; Freeman, A; Klocker, H; Masters, J; Williamson, M; (2011) A Role for Class 3 Semaphorins in Prostate Cancer. PROSTATE , 71 (6) pp. 649-658. 10.1002/pros.21281.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; Lee, JS; (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) pp. 3996-4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; Switzer, GE; (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Boshoff, C; (2011) Unraveling virus-induced lymphomagenesis. J CLIN INVEST , 121 (3) 838 - 841. 10.1172/JCI46499. Gold open access

Bouma, G; Mendoza-Naranjo, A; Blundell, MP; de Falco, E; Parsley, KL; Burns, SO; Thrasher, AJ; (2011) Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. BLOOD , 118 (9) 2492 - 2501. 10.1182/blood-2011-03-340265.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) pp. 742-744. 10.1093/ndt/gfq644.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? NEPHROL DIAL TRANSPL , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Bridgewater, JA; Stubbs, C; Primrose, JN; National Cancer Research Institute (UK) Upper Gastrointestinal S, ; (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol , 29 (15_suppl) 4125-.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; Costa-Cabral, S; (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) pp. 260-273. 10.1158/2159-8290.CD-11-0107.

Brown, NF; Marks, DJ; Smith, PJ; Bloom, SL; (2011) Splenomegaly. Br J Hosp Med (Lond) , 72 (11) M166-M169.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; Hartley, JA; (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, HT; Tan, D; Yap, T; de Bono, J; Barriuso, J; (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401-. 10.1155/2011/861401.

Bustamante, J; Arias, AA; Vogt, G; Picard, C; Galicia, LB; Prando, C; Grant, AV; (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol , 12 (3) pp. 213-221. 10.1038/ni.1992.

C

Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , 205 (1) 10.1016/j.ajog.2011.02.051.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; Bose, F; (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) pp. 3669-3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; Drelichman, G; (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carpenter, L; Malladi, R; Yang, C-T; French, A; Pilkington, KJ; Forsey, RW; Sloane-Stanley, J; (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) pp. 4008-4011. 10.1182/blood-2010-08-299941.

Carrera-Marin, AL; Romay-Penabad, Z; Machin, S; Cohen, H; Weston-Davies, W; Pierangeli, SS; (2011) C5 Inhibitor rEV576 Ameliorates In Vivo Effects of Antiphospholipid Antibodies. In: (Proceedings) 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S5-S5). WILEY-BLACKWELL

Carrera-Marin, AL; Romay-Penabad, Z; Weston-Davis, W; Machin, S; Cohen, H; Pierangeli, SS; (2011) C5 inhibitor rEV576 ameliorates in vivo effects of antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 290.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) pp. 3328-3340. 10.1158/0008-5472.CAN-10-2734.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Cheng, F; Pekkonen, P; Laurinavicius, S; Sugiyama, N; Henderson, S; Guenther, T; Rantanen, V; (2011) KSHV-Initiated Notch Activation Leads to Membrane-Type-1 Matrix Metalloproteinase-Dependent Lymphatic Endothelial-to-Mesenchymal Transition. CELL HOST & MICROBE , 10 (6) pp. 577-590. 10.1016/j.chom.2011.10.011.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) pp. 366-371. 10.1016/j.ymeth.2010.12.022.

Chua, MLK; Somaiah, N; A'Hern, R; Davies, S; Gothard, L; Yarnold, J; Rothkamm, K; (2011) Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. RADIOTHER ONCOL , 99 (3) 362 - 366. 10.1016/j.radonc.2011.05.071.

Chua, MLK; Somaiah, N; Bourne, S; Daley, F; A'Hern, R; Nuta, O; Davies, S; (2011) Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. RADIOTHER ONCOL , 99 (2) 225 - 230. 10.1016/j.radonc.2011.04.009.

Conde, L; Bevan, S; Sitzer, M; Klopp, N; Illig, T; Thiery, J; Seissler, J; (2011) Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling. Atherosclerosis , 219 (2) pp. 684-689. 10.1016/j.atherosclerosis.2011.08.031.

Conde, L; Bracci, PM; Halperin, E; Skibola, CF; (2011) A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics , 98 (1) pp. 9-14. 10.1016/j.ygeno.2011.03.007.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) pp. 1409-1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA, ; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Conrad, DF; Keebler, JE; DePristo, MA; Lindsay, SJ; Zhang, Y; Casals, F; Idaghdour, Y; (2011) Variation in genome-wide mutation rates within and between human families. Nat Genet , 43 (7) pp. 712-714. 10.1038/ng.862.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S; (2011) Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse. PLOS ONE , 6 (10) , Article e26002. 10.1371/journal.pone.0026002. Green open access
file

Counsell, N; Cortina-Borja, M; Lehtonen, A; Stein, A; (2011) Modelling psychiatric measures using Skew-Normal distributions. EUR PSYCHIAT , 26 (2) 112 - 114. 10.1016/j.eurpsy.2010.08.006.

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; Thompson, R; (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLINICAL CANCER RESEARCH , 17 (18) pp. 6083-6096. 10.1158/1078-0432.CCR-11-0945.

Cox, S.T.; (2011) The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome. Doctoral thesis, UCL (University College London). Green open access
file

Cox, ST; Stephens, HA; Fernando, R; Karasu, A; Harber, M; Howie, AJ; Powis, S; (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol , 72 (10) pp. 827-834. 10.1016/j.humimm.2011.05.004.

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

D

Dancey, G.S.; (2011) Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents. Doctoral thesis, UCL (University College London). Green open access
file

Danecek, P; Auton, A; Abecasis, G; Albers, CA; Banks, E; DePristo, MA; Handsaker, RE; (2011) The variant call format and VCFtools. Bioinformatics , 27 (15) pp. 2156-2158. 10.1093/bioinformatics/btr330.

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

De, S; Varsally, W; Falciani, F; Brogna, S; (2011) Ribosomal proteins' association with transcription sites peaks at tRNA genes in Schizosaccharomyces pombe. RNA , 17 (9) pp. 1713-1726. 10.1261/rna.2808411.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; Chi, KN; (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 364 (21) pp. 1995-2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; Luc, S; (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENETICS & CHROMATIN , 4 (ARTN 9) 10.1186/1756-8935-4-9. Gold open access

Dedes, KJ; Wetterskog, D; Ashworth, A; Kaye, SB; Reis-Filho, JS; (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 261-271. 10.1038/nrclinonc.2010.216.

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle , 10 (8) pp. 1192-1199. 10.4161/cc.10.8.15273.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; Davidoff, AM; (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, Y; Pirzada, ZA; Eckert, MR; (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature , 471 (7340) pp. 602-607. 10.1038/nature09886.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; Zhang, Y; (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202-U618. 10.1053/j.gastro.2011.06.065.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) The danger to cytopathology of over-specialization and its relevance for histopathology. CYTOPATHOLOGY , 22 (2) 140 - 140. 10.1111/j.1365-2303.2011.00865.x.

Doebroessy, M; Klein, A; Janghra, N; Nikkhah, G; Dunnett, SB; (2011) Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease. JOURNAL OF NEUROSCIENCE METHODS , 197 (1) pp. 6-13. 10.1016/j.jneumeth.2011.01.015.

Donaldson, J; Khan, WS; Tailor, H; Hughes, DA; Mehta, AB; Maruthainar, N; (2011) Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. HIP INTERNATIONAL , 21 (6) pp. 665-671. 10.5301/HIP.2011.8826.

Dragovic, RA; Gardiner, C; Brooks, AS; Tannetta, DS; Ferguson, DJ; Hole, P; Carr, B; (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine , 7 (6) pp. 780-788. 10.1016/j.nano.2011.04.003.

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. J Clin Oncol , 29 (15_suppl) 3104-.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; Delgado, J; (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; Prevost, T; (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Duhamel, L.A.E.; (2011) The role of LKB1 in the pathogenesis of Osteosarcoma. Doctoral thesis, UCL (University College London). Green open access
file

Dunn, JM; Banks, MR; Oukrif, D; Mackenzie, GD; Thorpe, S; Rodriguez-Justo, M; Winstanley, A; (2011) Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. ENDOSCOPY , 43 (7) 627 - 630. 10.1055/s-0030-1256443.

Dunn, JM; Hveem, T; Pretorius, M; Oukrif, D; Nielsen, B; Albregtsen, F; Lovat, LB; (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. BRIT J CANCER , 105 (8) 1218 - 1223. 10.1038/bjc.2011.353.

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Rodriguez-Justo, M; (2011) A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S215 - S216). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Winstanley, A; (2011) A RANDOMISED CONTROLLED TRIAL OF ALA VERSUS PHOTOFRIN PDT FOR HIGH GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A172 - A172). B M J PUBLISHING GROUP

Dunn, JM; McDonald, SA; Oukrif, D; Haidry, RJ; Butt, MA; Lovat, E; Lovat, LB; (2011) PLK-1 IS UPREGULATED IN BARRETT'S ADENOCARCINOMA AND IS A SURROGATE MARKER OF ANEUPLOIDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

E

El-Sharkawi, D; Basu, S; Qian, W; D'Sa, S; Hoskin, P; Ardeshna, K; (2011) LACTATE DEHYDROGENASE LEVELS DO NOT PREDICT RELAPSE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA. In: ANNALS OF ONCOLOGY. (pp. 223 - 223). OXFORD UNIV PRESS

El-Sharkawi, D; Ramsay, A; Cwynarski, K; Hughes, D; Prentice, A; Davies, N; Goode, A; (2011) Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. LEUKEMIA LYMPHOMA , 52 (11) 2130 - 2134. 10.3109/10428194.2011.589546.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; Hughes, DA; (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Endesfelder, D; McGranahan, N; Birkbak, NJ; Szallasi, Z; Kschischo, M; Graham, TA; Swanton, C; (2011) A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. ONCOTARGET , 2 (7) pp. 529-537.

Ertemi, H; Mumtaz, FH; Howie, AJ; Mikhailidis, DP; Thompson, CS; (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

Escors, D; Bricogne, C; Arce, F; Kochan, G; Karwacz, K; (2011) On the Mechanism of T cell receptor down-modulation and its physiological significance. J Biosci Med , 1 (1)

Evans, IM; Yamaji, M; Britton, G; Pellet-Many, C; Lockie, C; Zachary, IC; Frankel, P; (2011) Neuropilin-1 Signaling through p130(Cas) Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells. MOLECULAR AND CELLULAR BIOLOGY , 31 (6) pp. 1174-1185. 10.1128/MCB.00903-10.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

F

Faelber, K; Posor, Y; Gao, S; Held, M; Roske, Y; Schulze, D; Haucke, V; (2011) Crystal structure of nucleotide-free dynamin. Nature , 477 (7366) pp. 556-560. 10.1038/nature10369.

Feber, A; Wilson, GA; Zhang, L; Presneau, N; Idowu, B; Down, TA; Rakyan, VK; (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Research , 21 (4) pp. 515-524. 10.1101/gr.109678.110. Gold open access

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; Luketich, JD; (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; Whatcott, A; (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; Yiin, JJ; (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) pp. 4670-4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , 43 (1) pp. 47-59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. TRANSPLANTATION , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27.

Ferrer, IR; Araki, K; Ford, ML; (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant , 11 (4) pp. 654-659. 10.1111/j.1600-6143.2011.03473.x.

Ferrer, IR; Wagener, ME; Song, M; Kirk, AD; Larsen, CP; Ford, ML; (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A , 108 (51) pp. 20701-20706. 10.1073/pnas.1105500108.

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM pp. 231-237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Fisher, R; Larkin, J; Swanton, C; (2011) Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity. EPMA J , 3 (1) 1-. 10.1007/s13167-011-0137-3.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Chen, Y; Clapham, P; (2011) Ensembl 2011. Nucleic Acids Res , 39 (Database) D800-D806. 10.1093/nar/gkq1064.

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Foroni, L; Wilson, G; Gerrard, G; Mason, J; Grimwade, D; White, HE; de Castro, DG; (2011) Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 153 (2) pp. 179-190. 10.1111/j.1365-2141.2011.08603.x.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, CJ; (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 302-306. 10.1038/nrclinonc.2011.42.

Foxall, RB; Albuquerque, AS; Soares, RS; Baptista, AP; Cavaleiro, R; Tendeiro, R; Gomes, P; (2011) Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia. AIDS , 25 (16) pp. 1961-1970. 10.1097/QAD.0b013e32834b3554.

Furniss, D; Blandford, AE; Mayer, A; (2011) Considering Unremarkable Computing for Healthcare. Presented at: Workshop on Interactive Systems in Healthcare (WISH), Workshop at AMIA 2011 Annual Symposium.

Furniss, D; Blandford, AE; Rajkomar, A; Vincent, C; Mayer, A; (2011) The visible and the invisible: Distributed Cognition for medical devices. In: Blandford, A and De Pietro, G and Gallo, L and Gimblett, A and Oladimeji, P and Thimbleby, H, (eds.) EICS4Med 2011: Proceedings of the 1st International Workshop on Engineering Interactive Computing Systems for Medicine and Health Care: Pisa, Italy: June, 2011. (pp. pp. 1-6). CEUR Green open access
file

Furstenberg, A; Walsh, SB; Howie, A; Jones, G; Unwin, RJ; (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , 80 (1) pp. 31-39. 10.1016/j.critrevonc.2010.10.009.

G

Gadaleta, RM; Oldenburg, B; Willemsen, EC; Spit, M; Murzilli, S; Salvatore, L; Klomp, LW; (2011) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine. Biochim Biophys Acta , 1812 (8) pp. 851-858. 10.1016/j.bbadis.2011.04.005.

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

García-Gómez, JJ; Babiano, R; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Nop6, a component of 90S pre-ribosomal particles, is required for 40S ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA Biol , 8 (1) pp. 112-124.

García-Gómez, JJ; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Dynamics of the putative RNA helicase Spb4 during ribosome assembly in Saccharomyces cerevisiae. Mol Cell Biol , 31 (20) pp. 4156-4164. 10.1128/MCB.05436-11.

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: (pp. p. 169).

Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CW; Sargent, IL; (2011) Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One , 6 (10) , Article e26313. 10.1371/journal.pone.0026313.

Germani, G; Hytiroglou, P; Fotiadu, A; Burroughs, AK; Dhillon, AP; (2011) Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update. SEMIN LIVER DIS , 31 (1) 82 - 90. 10.1055/s-0031-1272836.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; Szydlo, R; (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. AMERICAN JOURNAL OF HEMATOLOGY , 86 (3) pp. 313-315. 10.1002/ajh.21954.

Gillmore, R; Stuart, S; Kirkwood, A; Hameeduddin, A; Woodward, N; Burroughs, AK; Meyer, T; (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation. JOURNAL OF HEPATOLOGY , 55 (6) pp. 1309-1316.

Glynne-Jones, R; Sebag-Montefiore, D; Adams, R; McDonald, A; Gollins, S; James, R; Northover, JMA; (2011) "MIND THE GAP"-THE IMPACT OF VARIATIONS IN THE DURATION OF THE TREATMENT GAP AND OVERALL TREATMENT TIME IN THE FIRST UK ANAL CANCER TRIAL (ACT I). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 81 (5) pp. 1488-1494. 10.1016/j.ijrobp.2010.07.1995.

Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; Woll, P; (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) pp. 138-152. 10.1016/j.ccr.2010.12.012.

Goh, V; Shastry, M; Engledow, A; Reston, J; Wellsted, DM; Peck, J; Endozo, R; (2011) Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. Eur Radiol , 21 (4) pp. 744-749. 10.1007/s00330-010-1967-4.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1653-1665. 10.1586/ERA.11.145.

Golubnitschaja, O; Swanton, C; Danesi, R; Costigliola, V; (2011) Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J , 2 (2) pp. 131-136. 10.1007/s13167-011-0088-8.

Goold, HD; Escors, D; Conlan, TJ; Chakraverty, R; Bennett, CL; (2011) Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors. J IMMUNOL , 186 (8) 4565 - 4572. 10.4049/jimmunol.1002529. Gold open access

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; Kanki, JP; (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. LEUKEMIA , 25 (3) pp. 506-514. 10.1038/leu.2010.280.

Graham, TA; Humphries, A; Sanders, T; Rodriguez-Justo, M; Tadrous, PJ; Preston, SL; Novelli, MR; (2011) Use of methylation patterns to determine expansion of stem cell clones in human colon tissue. Gastroenterology , 140 (4) 1241-1250.e1-9-. 10.1053/j.gastro.2010.12.036.

Green, CL; Evans, CM; Zhao, L; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2011) The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. BLOOD , 118 (2) 409 - 412. 10.1182/blood-2010-12-322479.

Green, L; De Lord, C; Clark, B; Cadet, E; Rochette, J; Thein, SL; (2011) Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload. Br J Haematol , 154 (3) 288-. 10.1111/j.1365-2141.2011.08666.x.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Groves, AM; Shastry, M; Rodriguez-Justo, M; Malhotra, A; Endozo, R; Davidson, T; Kelleher, T; (2011) F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. EUR J NUCL MED MOL I , 38 (1) 46 - 52. 10.1007/s00259-010-1590-2.

Guerra, C; Collado, M; Navas, C; Schuhmacher, AJ; Hernández-Porras, I; Cañamero, M; Rodriguez-Justo, M; (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell , 19 (6) pp. 728-739. 10.1016/j.ccr.2011.05.011.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) pp. 7151-7157. 10.1016/j.bmc.2011.09.055.

Guppy, A; Jamal-Hanjani, M; Pickering, L; (2011) Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncol , 7 (6) pp. 727-736. 10.2217/fon.11.49.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; Payne, E; (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) pp. 1595-1603. 10.1084/jem.20101691.

Gutierrez-Gonzalez, L; Graham, TA; Rodriguez-Justo, M; Leedham, SJ; Novelli, MR; Gay, LJ; Ventayol-Garcia, T; (2011) The Clonal Origins of Dysplasia From Intestinal Metaplasia in the Human Stomach. GASTROENTEROLOGY , 140 (4) 1251-+. 10.1053/j.gastro.2010.12.051.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) pp. 1588-1599. 10.1002/glia.21201.

H

Hackshaw, A; Kirkwood, A; (2011) Interpreting and reporting clinical trials with results of borderline significance. BMJ , 343 d3340-.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; Enver, T; (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 580). AMER SOC HEMATOLOGY

Hall, A; Isgro, G; Morris, R; Burroughs, AK; Dhillon, AP; (2011) SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S133-S133). ELSEVIER SCIENCE BV

Harding, J.; (2011) Small RNAs as regulators of early vertebrate development. Doctoral thesis, UCL (University College London). Green open access
file

Harrison, JD; Rodriguez-Justo, M; (2011) Commentary on IgG4-related sialadenitis: Mikulicz's disease, Küttner's tumour, and eponymy. Histopathology , 58 (7) pp. 1164-1166. 10.1111/j.1365-2559.2011.03824.x.

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; Machin, S; (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 930-931.

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: (Proceedings) Annual Meeting of the American-Society-for-Cell-Biology (ASCB). AMER SOC CELL BIOLOGY

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 pp. 309-320. 10.1007/978-1-61779-080-5_25.

Hartmann, S; Agostinelli, C; Klapper, W; Korkolopoulou, P; Koch, K; Marafioti, T; Piccaluga, PP; (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? HISTOPATHOLOGY , 59 (6) pp. 1173-1182. 10.1111/j.1365-2559.2011.04069.x.

Hayee, B; Antonopoulos, A; Murphy, EJ; Rahman, FZ; Sewell, G; Smith, BN; McCartney, S; (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. GLYCOBIOLOGY , 21 (7) 914 - 924. 10.1093/glycob/cwr023.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; Vanhaesebroeck, B; (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) pp. 278-287. 10.1016/j.jaut.2011.02.006.

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Herzog, B; Pellet-Many, C; Britton, G; Hartzoulakis, B; Zachary, IC; (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell , 22 (15) 2766 - 2776. 10.1091/mbc.E09-12-1061. Green open access
file

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; (2011) RITUXIMAB PLUS CHLORAMBUCIL (R-CHLORAMBUCIL) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): FINAL ANALYSIS OF AN OPEN-LABEL PHASE II STUDY. In: ANNALS OF ONCOLOGY. (pp. 123 - 123). OXFORD UNIV PRESS

Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; Evans, S; (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; Krystal, G; (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) pp. 866-875. 10.1016/j.cellsig.2011.01.012.

Hollenbach, JA; Mack, SJ; Gourraud, P-A; Single, RM; Maiers, M; Middleton, D; Thomson, G; (2011) A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. TISSUE ANTIGENS , 78 (5) pp. 333-344. 10.1111/j.1399-0039.2011.01777.x.

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) pp. 150-151. 10.1111/j.1440-1754.2010.01741.x.

Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) pp. 1197-1205. 10.1007/s00467-010-1701-0.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) pp. 771-772.

Hughes, D; Barba-Romero, MA; Hollak, CE; Giugliani, R; Deegan, PB; (2011) DELAYED MENARCHE AND EARLY MENOPAUSE IN FEMALES WITH FABRY DISEASE. JOURNAL OF INHERITED METABOLIC DISEASE , 34 S186-S186.

Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; Cohen, IJ; (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators, ; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.

I

Ibrahim, AR; Eliasson, L; Apperley, JF; Milojkovic, D; Bua, M; Szydlo, R; Mahon, F-X; (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. BLOOD , 117 (14) pp. 3733-3736. 10.1182/blood-2010-10-309807.

Isgro, G; Andreana, L; Garcovich, M; Luong, TV; Hall, A; Manousou, P; Goossens, N; (2011) COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S69-S70). ELSEVIER SCIENCE BV

Isgro, G; Hall, AR; Andreana, L; Luong, T; Burroughs, AK; Dhillon, AP; (2011) EDITED AND NON-EDITED COLLAGEN PROPORTIONATE AREA: PREDICTION OF DECOMPENSATION IN CIRRHOSIS. In: HEPATOLOGY. (pp. 1276A - 1276A). WILEY-BLACKWELL

J

JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; McMahan, CA; (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

Jamal-Hanjani, M; Pettengell, R; (2011) Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. Expert Opin Drug Metab Toxicol , 7 (11) pp. 1441-1448. 10.1517/17425255.2011.618834.

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Jiao, Y; Lawler, K; Patel, GS; Purushotham, A; Jones, AF; Grigoriadis, A; Tutt, A; (2011) DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC BIOINFORMATICS , 12 (ARTN 403) 10.1186/1471-2105-12-403. Gold open access

Johansson, AM; Hill, N; Perisoglou, M; Whelan, J; Karlsson, MO; Standing, JF; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Therapeutic Drug Monitoring , 33 (6) pp. 711-718. 10.1097/FTD.0b013e31823615e1.

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; Whelan, J; (2011) Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (34) pp. 4534-4540. 10.1200/JCO.2010.33.0670.

K

Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; Linch, DC; (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 68). AMER SOC HEMATOLOGY

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kapoor, RR; Flanagan, SE; James, CT; McKiernan, J; Thomas, AM; Harmer, SC; Shield, JP; (2011) Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia , 54 (10) pp. 2575-2583. 10.1007/s00125-011-2207-4. Green open access
file

Karwacz, K; Bricogne, C; MacDonald, D; Arce, F; Bennett, CL; Collins, M; Escors, D; (2011) PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells. EMBO MOL MED , 3 (10) 581 - 592. 10.1002/emmm.201100165. Gold open access

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access
file

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Katodritou, E; Terpos, E; North, J; Kottaridis, P; Verrou, E; Gastari, V; Chadjiaggelidou, C; (2011) Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. AMERICAN JOURNAL OF HEMATOLOGY , 86 (12) pp. 967-973. 10.1002/ajh.22163.

Keane, TM; Goodstadt, L; Danecek, P; White, MA; Wong, K; Yalcin, B; Heger, A; (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature , 477 (7364) pp. 289-294. 10.1038/nature10413.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; Sukkurwala, AQ; (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) pp. 61-69. 10.1007/s10555-011-9273-4.

Khan, AB; Lipman, M; Hopkins, S; Marshall, N; Galloway, M; Kibbler, C; (2011) Poor outcome of central nervous system invasive aspergillosis in HIV infection despite galactomannan-based diagnosis: A case series and literature review. Infectious Diseases in Clinical Practice , 19 (4) pp. 299-302. 10.1097/IPC.0b013e3182041769.

Khan, MS; El-Khouly, F; Davies, P; Toumpanakis, C; Caplin, ME; (2011) Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 34 (2) pp. 235-242. 10.1111/j.1365-2036.2011.04693.x.

Khan, MS; El-Khouly, F; Quigley, AM; Caplin, M; Toumpanakis, C; (2011) Y90-DOTATATE in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Survival following Different Indications for Treatment. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, T; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Rashid, M; Rabouhans, JS; Yu, D; Tu, VL; Caplin, M; (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Khwaja, A; Quinn, J; Yong, KL; (2011) The myeloma bone marrow environment and survival signaling. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 64-83).

Kimata, Y; Kitamura, K; Fenner, N; Yamano, H; (2011) Mes1 controls the meiosis I to meiosis II transition by distinctly regulating the anaphase-promoting complex/cyclosome coactivators Fzr1/Mfr1 and Slp1 in fission yeast. MOL BIOL CELL , 22 (9) 1486 - 1494. 10.1091/mbc.E10-09-0774. Gold open access

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant , 46 (1) pp. 10-13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green open access
file

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; Roughton, M; (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (18_suppl) LBA5006-.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (15_suppl) LBA5006-.

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; Menger, L; (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) pp. 130-138.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; Keppler, M; (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; Hart, SL; (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; Hirose, M; (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23-. 10.1126/scisignal.2001617.

Kumar, MS; Swanton, C; (2011) KRAS 3'-UTR variants and stratification of breast-cancer risk. Lancet Oncol , 12 (4) pp. 318-319. 10.1016/S1470-2045(11)70065-1.

L

Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) pp. 324-333.

Lambrianides, A; Turner-Stokes, T; Pericleous, C; Ehsanullah, J; Papadimitraki, E; Poulton, K; Ioannou, Y; (2011) Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis. ARTHRITIS AND RHEUMATISM , 63 (11) pp. 3512-3521. 10.1002/art.30525.

Larkin, J; Swanton, C; Pickering, L; (2011) Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action. Expert Rev Anticancer Ther , 11 (4) pp. 639-649. 10.1586/era.11.21.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; Dafou, D; (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) pp. 1540-1549. 10.1093/carcin/bgr140.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Lawson, AR; Hindley, GF; Forshew, T; Tatevossian, RG; Jamie, GA; Kelly, GP; Neale, GA; (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res , 21 (4) pp. 505-514. 10.1101/gr.115782.110.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; Earl, H; (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJ; Scott, C; (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). J Clin Oncol , 29 (15_suppl) 5003-.

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; McNeish, I; (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. EUROPEAN JOURNAL OF CANCER , 47 S104-S115.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; Downward, J; (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) pp. 1858-1870. 10.1158/0008-5472.CAN-10-3604.

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Li, Q; Birkbak, NJ; Gyorffy, B; Szallasi, Z; Eklund, AC; (2011) Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics , 12 474-. 10.1186/1471-2105-12-474.

Li, Q; Eklund, AC; Birkbak, NJ; Desmedt, C; Haibe-Kains, B; Sotiriou, C; Symmans, WF; (2011) Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response. BMC Bioinformatics , 12 310-. 10.1186/1471-2105-12-310.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; Kheradpour, P; (2011) A high-resolution map of human evolutionary constraint using 29 mammals. NATURE , 478 (7370) pp. 476-482. 10.1038/nature10530.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; Green, T; (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists Thyroid Fine-Needle Aspiration Diagnostic Classification Is a Robust Tool for the Clinical Management of Abnormal Thyroid Nodules. ACTA CYTOLOGICA , 55 (6) pp. 499-506. 10.1159/000333234.

Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; Yang, SP; (2011) Comparative and demographic analysis of orang-utan genomes. Nature , 469 (7331) pp. 529-533. 10.1038/nature09687.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; Twigger, K; (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) pp. 581-588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; Aguillon, JC; (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; Remuzzi, G; (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; Rossig, C; (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood , 118 (23) pp. 6050-6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; Linch, D; (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) pp. 86-92. 10.1016/j.radonc.2011.05.013.

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; Mead, AJ; (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1011). AMER SOC HEMATOLOGY

M

Ma, GL; Dhillon, AP; Hall, AR; Burroughs, AK; Tsochatzis, E; Burgess, G; Guo, F; (2011) ISHAK STAGE PROGRESSION RATE MODELING FOR POST LIVER TRANSPLANT (POLT) PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION. In: HEPATOLOGY. (pp. 579A - 579A). WILEY-BLACKWELL

Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; (2011) Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. BLOOD CELLS MOLECULES AND DISEASES , 47 (3) pp. 166-175. 10.1016/j.bcmd.2011.07.002.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; Dragovich, T; (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; Burnell, M; (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mandeville, H.C.; (2011) Exploration of the clinical interaction between vascular targeting agents and radiotherapy. Doctoral thesis, UCL (University College London). Green open access
file

Manousou, P; Dhillon, AP; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Xirouchakis, E; (2011) Digital Image Analysis of Liver Collagen Predicts Clinical Outcome of Recurrent Hepatitis C Virus 1 Year After Liver Transplantation. LIVER TRANSPLANT , 17 (2) 178 - 188. 10.1002/lt.22209.

Manousou, P; Kalambokis, G; Grillo, F; Watkins, J; Xirouchakis, E; Pleguezuelo, M; Leandro, G; (2011) Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. LIVER INT , 31 (5) 730 - 739. 10.1111/j.1478-3231.2011.02488.x.

Mansour, MR; Look, AT; (2011) Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma. CANCER CELL , 20 (5) pp. 559-561. 10.1016/j.ccr.2011.10.027.

Mansur, A; Little, MA; Oh, WC; Jacques, S; Nightingale, P; Howie, AJ; Savage, COS; (2011) Immune Profile and Epstein-Barr Virus Infection in Acute Interstitial Nephritis: An Immunohistochemical Study in 78 Patients. NEPHRON CLINICAL PRACTICE , 119 (4) C293-C300. 10.1159/000329671.

Markert, ML; Marques, JG; Neven, B; Devlin, BH; McCarthy, EA; Chinn, IK; Albuquerque, AS; (2011) First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood , 117 (2) pp. 688-696. 10.1182/blood-2010-06-292490.

Marsh, D; Suchak, K; Moutasim, KA; Vallath, S; Hopper, C; Jerjes, W; Upile, T; (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Marsh, D.J.; (2011) The αvβ6 Integrin in cancer. Doctoral thesis, UCL (University College London). Green open access
file

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2010. TISSUE ANTIGENS , 77 (2) pp. 167-175. 10.1111/j.1399-0039.2010.01595.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update February 2011. TISSUE ANTIGENS , 77 (6) pp. 613-617. 10.1111/j.1399-0039.2011.01688.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update January 2011. TISSUE ANTIGENS , 77 (6) pp. 603-612. 10.1111/j.1399-0039.2011.01687.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update November 2010. TISSUE ANTIGENS , 77 (4) pp. 355-361. 10.1111/j.1399-0039.2011.01643.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update October 2010. TISSUE ANTIGENS , 77 (4) pp. 349-354. 10.1111/j.1399-0039.2011.01644.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2010. TISSUE ANTIGENS , 77 (3) pp. 268-270. 10.1111/j.1399-0039.2010.01604.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update September 2011. TISSUE ANTIGENS , 78 (6) pp. 482-484. 10.1111/j.1399-0039.2011.01797.x.

Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; Michaud, M; (2011) Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene , 30 (10) pp. 1147-1158. 10.1038/onc.2010.500.

Masir, N; Jones, M; Marafioti, T; Mason, DY; (2011) Heterogeneous expression of B cell-associated markers in follicular lymphoma. Histopathology , 58 (4) pp. 633-636. 10.1111/j.1365-2559.2011.03782.x.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; Mcintosh, J; (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Maughan, T; Wilson, RH; Williams, GT; Seymour, MT; Richman, S; Quirke, P; Pope, M; (2011) Developing a biomarker-stratified trial design in advanced colorectal cancer: The MRC FOCUS 3 feasibility study. J Clin Oncol , 29 (15_suppl) TPS165-.

Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; Idziaszczyk, S; (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) pp. 2103-2114. 10.1016/S0140-6736(11)60613-2.

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) pp. 2845-2856. 10.1210/en.2010-1256.

McCaughan, F; Pipinikas, CP; Janes, SM; George, PJ; Rabbitts, PH; Dear, PH; (2011) Genomic evidence of pre-invasive clonal expansion, dispersal and progression in bronchial dysplasia. J PATHOL , 224 (2) 153 - 159. 10.1002/path.2887.

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 915-916.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; Delord, J-P; (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. BRITISH JOURNAL OF CANCER , 105 (11) pp. 1646-1653. 10.1038/bjc.2011.438.

Mellars, G; Gomez, K; (2011) Mutation detection by Southern blotting. Methods Mol Biol , 688 pp. 281-291. 10.1007/978-1-60761-947-5_19.

Mendoza-Naranjo, A; Bouma, G; Pereda, C; Ramirez, M; Webb, KF; Tittarelli, A; Lopez, MN; (2011) Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation. J IMMUNOL , 187 (6) 3121 - 3132. 10.4049/jimmunol.1100378.

Menezes, LJ; Kotze, CW; Agu, O; Richards, T; Brookes, J; Goh, VJ; Rodriguez-Justo, M; (2011) Investigating Vulnerable Atheroma Using Combined F-18-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation. J NUCL MED , 52 (11) 1698 - 1703. 10.2967/jnumed.111.093724.

Meyer, C; Sevko, A; Ramacher, M; Bazhin, AV; Falk, CS; Osen, W; Borrello, I; (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) pp. 17111-17116. 10.1073/pnas.1108121108.

Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, Y; Pellegatti, P; Shen, S; (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science , 334 (6062) pp. 1573-1577. 10.1126/science.1208347.

Middleton, GW; Gwyther, SJ; Brown, SR; Maughan, T; Olivier, C; Richman, S; Maisey, NR; (2011) Biomodulation of irinotecan using ciclosporin: Results of PICCOLO, a randomized controlled trial in advanced colorectal cancer (aCRC). J Clin Oncol , 29 (15_suppl) 3566-.

Milojkovic, D; Apperley, JF; Ibrahim, AR; Bua, M; Reid, A; Gerrard, G; Foroni, L; (2011) Prolonged Survival Following Imatinib Failure for CML Patients in CP May Require Multiple TKI Strategies for Responding Patients. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 1613-1614). AMER SOC HEMATOLOGY

Milojkovic, D; Gerrard, G; Paliompeis, C; Bua, M; Reid, A; Alikian, M; Khorashad, J; (2011) The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for 'Stopping' Studies. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 278). AMER SOC HEMATOLOGY

Milojkovic, D; Ibrahim, AR; Foroni, L; Lucas, C; Gerrard, G; Wang, L; Szydlo, RM; (2011) Assessment of BCR-ABL1 Transcript Levels At 3 Months Is the Only Requirement for Predicting Outcome for Patients with Chronic Myeloid Leukemia Treated with Imatinib. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 729). AMER SOC HEMATOLOGY

Mindell, J; Aresu, M; Zaninotto, P; Falaschetti, E; Poulter, N; (2011) Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey-2006. Clinical Endocrinology , 75 (5) 621 - 627. 10.1111/j.1365-2265.2011.04094.x. Green open access
filefile

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohamedbhai, SG; Sibson, K; Marafioti, T; Kayani, I; Lowry, L; Goldstone, AH; Linch, DC; (2011) Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index > 95%. BRIT J HAEMATOL , 152 (2) 175 - 181. 10.1111/j.1365-2141.2010.08447.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; Evans, S; (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Moiseeva, VS; Motovilov, KA; Lobysheva, NV; Orlov, VN; Yaguzhinsky, LS; (2011) The formation of metastable bond between protons and mitoplast surface. Dokl Biochem Biophys , 438 pp. 127-130. 10.1134/S1607672911030069.

Moore, S; Peggs, K; Thomson, K; Ljubic, A; Goldstone, AH; Linch, DC; Ardeshna, K; (2011) AUTOLOGOUS STEM CELL TRANSPLANTATION REMAINS BENEFICIAL FOR PATIENTS RELAPSING AFTER R-CHOP AND WHO RESPOND TO SALVAGE CHEMOTHERAPY. In: ANNALS OF ONCOLOGY. (pp. 107 - 107). OXFORD UNIV PRESS

Morris, C; Cook, G; Streetly, M; Kettle, P; Drake, M; Quinn, M; Cavet, J; (2011) Re-transplantation after bortezomib-based therapy. BRITISH JOURNAL OF HAEMATOLOGY , 153 (5) pp. 666-668. 10.1111/j.1365-2141.2010.08521.x.

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; Kwiatkowski, JL; (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

Myers, RM; Stamatoyannopoulos, J; Snyder, M; Dunham, I; Hardison, RC; Bernstein, BE; Gingeras, TR; (2011) A user's guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biology , 9 (4) , Article e1001046. 10.1371/journal.pbio.1001046. Green open access
file

N

Naqvi, N; Davidson, SJ; Wong, D; Cullinan, P; Roughton, M; Doughty, VL; Franklin, RC; (2011) Predicting 22q11.2 deletion syndrome: a novel method using the routine full blood count. Int J Cardiol , 150 (1) pp. 50-53. 10.1016/j.ijcard.2010.02.027.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; Nawathe, S; (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Linch, DC; Chowdary, P; (2011) Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B. NEW ENGLAND JOURNAL OF MEDICINE , 365 (25) pp. 2357-2365. 10.1056/NEJMoa1108046.

Nathwani, AC; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, JH; Linch, DC; Chowdary, P; (2011) Adeno-Associated Viral Vector Mediated Gene Transfer for Hemophilia B. BLOOD , 118 (21) pp. 4-5.

Navani, N; Booth, HL; Kocjan, G; Falzon, M; Capitanio, A; Brown, JM; Porter, JC; (2011) Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. RESPIROLOGY , 16 (3) 467 - 472. 10.1111/j.1440-1843.2011.01933.x.

Navani, N; Nankivell, M; Nadarajan, P; Pereira, SP; Kocjan, G; Janes, SM; (2011) The learning curve for EBUS-TBNA. THORAX , 66 (4) 352 - 353. 10.1136/thx.2010.146407.

Navani, N; Nankivell, M; Woolhouse, I; Harrison, RN; Munavvar, M; Oltmanns, U; Falzon, M; (2011) Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Intrathoracic Lymphadenopathy in Patients with Extrathoracic Malignancy A Multicenter Study. J THORAC ONCOL , 6 (9) 1505 - 1509. 10.1097/JTO.0b013e318223c3fe.

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; Forni, GL; (2011) Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 315-316). AMER SOC HEMATOLOGY

Nicholson, E; Mackinnon, S; (2011) Relapsed AML post-allogeneic hematopoietic stem cell transplantation. Clin Adv Hematol Oncol , 9 (12) pp. 951-955.

Nicolaides, TP; Li, H; Solomon, DA; Hariono, S; Hashizume, R; Barkovich, K; Baker, SJ; (2011) Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res , 17 (24) pp. 7595-7604. 10.1158/1078-0432.CCR-11-1456.

O

O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Calcagnino, M; Murphy, E; Lachmann, R; (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace , 13 (12) pp. 1781-1788. 10.1093/europace/eur267.

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access

P

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; Arkenau, HT; (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) pp. 1561-1570. 10.1158/1078-0432.CCR-10-1927.

Partridge, L; Alic, N; Bjedov, I; Piper, MDW; (2011) Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Experimental Gerontology , 46 (5) 376 - 381. 10.1016/j.exger.2010.09.003. Green open access
file

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; Steele, AJ; (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Paul, DS; Nisbet, JP; Yang, TP; Meacham, S; Rendon, A; Hautaviita, K; Tallila, J; (2011) Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet , 7 (6) , Article e1002139. 10.1371/journal.pgen.1002139. Green open access
file

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; Stone, R; (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. BLOOD , 118 (4) pp. 903-915. 10.1182/blood-2010-11-318022.

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1667-1670. 10.1586/ERA.11.159.

Peggs, KS; Kayani, I; Edwards, N; Kottaridis, P; Goldstone, AH; Linch, DC; Hough, R; (2011) Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell-Depleted Allogeneic Transplantation for Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (8) 971 - 978. 10.1200/JCO.2010.32.1711.

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; Pang, K; (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green open access
file

Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; Carey, MS; (2011) A Phase 3 Trial of Bevacizumab in Ovarian Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 365 (26) pp. 2484-2496. 10.1056/NEJMoa1103799.

Pillay, N; Amary, FM; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 does not regulate brachyury expression in human chordomas and osteosarcomas. HISTOPATHOLOGY , 59 (5) pp. 1025-1027. 10.1111/j.1365-2559.2011.03973.x.

Pitt, K; James, C; Kochar, IS; Kapoor, A; Jain, S; Hussain, K; Bennett, K; (2011) A single base-pair deletion in the WFS1 gene causes Wolfram syndrome. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , 24 (5-6) pp. 389-391. 10.1515/JPEM.2011.215.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; Tilby, MJ; (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Poiroux, G; Pitié, M; Culerrier, R; Lafont, E; Ségui, B; Van Damme, EJ; Peumans, WJ; (2011) Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy. PLoS One , 6 (8) , Article e23315. 10.1371/journal.pone.0023315. Green open access
file

Popat, R; Dickson, J; Khan, I; Cheesman, S; Percy, L; Moore, S; D'Sa, S; (2011) An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1797). AMER SOC HEMATOLOGY

Porakishvili, N; Memon, A; Vispute, K; Kulikova, N; Clark, EA; Rai, KR; Nathwani, A; (2011) CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 153 (4) 486 - 498. 10.1111/j.1365-2141.2011.08605.x.

Pors, K; Loadman, PM; Shnyder, SD; Sutherland, M; Sheldrake, HM; Guino, M; Kiakos, K; (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Porter, JB; Evangeli, M; El-Beshlawy, A; (2011) The challenges of adherence and persistence with iron chelation therapy. INTERNATIONAL JOURNAL OF HEMATOLOGY , 94 (5) pp. 453-460. 10.1007/s12185-011-0927-3.

Porter, JB; Lin, KH; Beris, P; Forni, GL; Taher, A; Habr, D; Domokos, G; (2011) Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. EUR J HAEMATOL , 87 (4) 338 - 348. 10.1111/j.1600-0609.2011.01660.x. Gold open access

Pospori, C; Xue, SA; Holler, A; Voisine, C; Perro, M; King, J; Fallah-Arani, F; (2011) Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination. BLOOD , 117 (25) 6813 - 6824. 10.1182/blood-2010-08-304568.

Presneau, N; Shalaby, A; Ye, H; Pillay, N; Halai, D; Idowu, B; Tirabosco, R; (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol , 223 (3) pp. 327-335. 10.1002/path.2816.

Presneau, N; Shalaby, A; Ye, HT; Pillay, N; Halai, D; Idowu, B; Tirabosco, R; (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J PATHOL , 223 (3) 327 - 335. 10.1002/path.2816.

Proctor, IE; McNamara, C; Rodriguez-Justo, M; Isaacson, PG; Ramsay, A; (2011) Importance of Expert Central Review in the Diagnosis of Lymphoid Malignancies in a Regional Cancer Network. J CLIN ONCOL , 29 (11) 1431 - 1435. 10.1200/JCO.2010.31.2223.

Puzanov, I; Lee, W; Chen, AP; Calcutt, MW; Hachey, DL; Vermeulen, WL; Spanswick, VJ; (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

Q

Quezada, SA; Peggs, KS; (2011) Tumor-reactive CD4(+) T cells: plasticity beyond helper and regulatory activities. IMMUNOTHERAPY-UK , 3 (8) 915 - 917. 10.2217/IMT.11.83.

Quezada, SA; Peggs, KS; Simpson, TR; Allison, JP; (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. IMMUNOL REV , 241 104 - 118. 10.1111/j.1600-065X.2011.01007.x.

Quinn, J; Glassford, J; Percy, L; Munson, P; Marafioti, T; Rodriguez-Justo, M; Yong, K; (2011) APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. BLOOD , 117 (3) pp. 890-901. 10.1182/blood-2010-01-264424.

R

Raj, D; Davidoff, AM; Nathwani, AC; (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. EXPERT REV HEMATOL , 4 (5) 539 - 549. 10.1586/EHM.11.48.